Bristol Myers Squibb to acquire schizophrenia drugmaker Karuna Therapeutics for $14B
Princeton-based Bristol Myers Squibb & Co. on Friday agreed to acquire Karuna Therapeutics Inc. for $330 ...
Read morePrinceton-based Bristol Myers Squibb & Co. on Friday agreed to acquire Karuna Therapeutics Inc. for $330 ...
Read morePTC Therapeutics on Thursday said it cut approximately 25% of its workforce. The South Plainfield-based biopharmaceutical ...
Read moreCopyright © 2023 www.homebuyerweekly.com | All Rights Reserved.